Brief: Codiak Biosciences Says Co, Jazz Pharmaceuticals Ireland Agreed To Discontinue Work On Exoaso™-Stat3
08/04/2021 21:48
April 8 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK BIOSCIENCES, INC. - ON APRIL 2, 2021, CO & JAZZ
PHARMACEUTICALS IRELAND MUTUALLY AGREED TO DISCONTINUE THEIR
WORK ON EXOASO™-STAT3
* CODIAK BIOSCIENCES- CO & JAZZ CONTINUE TO JOINTLY ADVANCE
THEIR
RESEARCH AND DEVELOPMENT EFFORTS ON OTHER EXOSOME-BASED
THERAPEUTIC PROGRAMS
Source text: (https://bit.ly/2Oy3JZ3)
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy